Alex Slack
Co-Founder @ Lauxera Capital Partners
Mill Valley, United States
Alex Slack is a Series D investor at Lauxera Capital Partners in Mill Valley focused on Biotechnology and Oncology. Alex Slack is the Founding Partner at Lauxera Capital Partners. He attended the Harvard University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Alex Slack invests in
Stages Alex Slack invests in
Countries Alex Slack invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (100%)
- Oncology 1 (50%)
- Life Science 1 (50%)
- Medical Device 1 (50%)
Stage
- Series D 1 (50%)
- Funding Round 1 (50%)
Country
- Sweden 1 (50%)
- The Netherlands 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells. | Sep 12, 2023 | ||
| LUMICKS delivers state-of-the-art technologies for the study of biology and cancer at the single-molecule and single-cell levels. It aims to build the unfinished bridge between structure and function at the molecular and cellular levels. Using its product C-Trap Optical Tweezers, Fluorescence Microscopy, scientists are able to analyze complexbiological processes in real-time. Similarly, the z-Movi Cell Avidity Analyzer enables the measurement and selection of immune cells based on their real-time interactions with target cells. | $93M / Series D / Apr 16, 2021 |
Co-Investors
About Lauxera Capital Partners
Lauxera Capital Partners is an independent, international, healthcare-focused asset management company. Our growth equity investments focus primarily on commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies. Led by entrepreneurial company builders and seasoned healthcare investors with experienceacross international markets, we empower European healthtech entrepreneurs to deliver the growth promised by their innovations.Lauxera was created in 2020 and has offices in Paris and San Francisco.
Lauxera Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alex Slack
Co-Founder
|
|||
Samuel Levy
Founding Partner
|
|||
|
Victor Decrion
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alex Slack invest in?
Alex Slack invests primarily in Biotechnology, Oncology and Life Science startups, most often at Series D and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alex Slack?
Public channels for Alex Slack include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alex Slack last invest?
The most recent investment recorded for Alex Slack closed in Sep 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
